Inrebic Interactions
There are 567 drugs known to interact with Inrebic (fedratinib), along with 9 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 184 are major, 358 are moderate, and 25 are minor.
- View all 567 medications that may interact with Inrebic
- View Inrebic alcohol/food interactions (1)
- View Inrebic disease interactions (9)
Most frequently checked interactions
View interaction reports for Inrebic (fedratinib) and the medicines listed below.
- Actimmune (interferon gamma-1b)
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Addyi (flibanserin)
- Adzynma (apadamtase alfa, recombinant)
- Aimovig (erenumab)
- Alhemo (concizumab)
- Altuviiio (antihemophilic factor)
- Alyftrek (deutivacaftor / tezacaftor / vanzacaftor)
- ambrisentan
- Amondys 45 (casimersen)
- Amvuttra (vutrisiran)
- Andembry (garadacimab)
- Anusol-HC Suppositories (hydrocortisone topical)
- apremilast
- Aquaphor (emollients topical)
- Aspir 81 (aspirin)
- Atacand (candesartan)
- atorvastatin
- Attruby (acoramidis)
- Aubagio (teriflunomide)
- Augtyro (repotrectinib)
- Austedo XR (deutetrabenazine)
- azithromycin
- Bafiertam (monomethyl fumarate)
- Benadryl Allergy Sinus (diphenhydramine / pseudoephedrine)
- Cymbalta (duloxetine)
- Eliquis (apixaban)
- levothyroxine
- metformin
Inrebic alcohol/food interactions
There is 1 alcohol/food interaction with Inrebic (fedratinib).
Inrebic disease interactions
There are 9 disease interactions with Inrebic (fedratinib) which include:
- severe hepatic impairment
- thiamine deficiency
- Fedratinib-gastrointestinal toxicity
- cardiovascular risk
- malignancy
- thrombosis
- renal impairment
- Fedratinib-cytopenias
- Fedratinib-pancreatitis
More about Inrebic (fedratinib)
- Inrebic consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.